News
Stay up to date on topics that are important to Nurse Practitioners.
-
First Respiratory Syncytial Virus (RSV) Vaccine for Adults 60 Years and Older Receives FDA Approval
On May 3rd, the FDA approved Arexvy, the first RSV vaccine available in the United States for individuals…
-
FDA Authorizes Changes to Simplify COVID-19 Vaccination Schedule
In order to simplify the vaccination schedule for most Americans, the U.S. Food and Drug Administration recently amended…
-
STI Cases in the United States Continue to Escalate
Recent data from the CDC shows that reported cases of sexually transmitted infections (STIs) have increased between 2020…
-
FDA Approves Naloxone Nasal Spray for Nonprescription Use
The U.S. Food and Drug Administration approved Narcan, 4 milligram (mg) naloxone hydrochloride nasal spray, for over-the-counter nonprescription…
-
Florida Proposes Bill to Restrict Use of Title “Dr.”
A recent bill filed in the Florida State Legislature would place significant restrictions on the use of the…
-
Two Cases of the H5N1 Strain of Avian Flu Found in Humans
Epidemiologists around the world are keeping a close eye on the H5N1 strain of avian influenza. Identified in…
-
FDA Recommends Approval for Two RSV Vaccines for Older Adults
An FDA advisory committee recommended that the agency approve two RSV vaccines for adults, one produced by GlaxoSmithKline,…
-
Eli Lilly Caps Out-Of-Pocket Insulin Costs at $35
After mounting pressure from government and advocacy groups, pharmaceutical giant Eli Lilly has announced a 70% reduction in…
-
Congress Introduces Legislation Authorizing NPs to Certify Patients’ Need for Diabetic Shoes
H.R.4870 / S.800, the bipartisan, bicameral “Promoting Access to Diabetic Shoes Act” proposes an amendment to the Social…
-
FDA Releases Draft Revisions to Blood Donor Eligibility Evaluations
The FDA has released draft guidelines revising recommendations for evaluating blood donor eligibility. The proposed evaluative guidelines will…
-
CDC and FDA Tracking Outbreak of Drug-Resistant Pseudomonas aeruginosa
The CDC and FDA are investigating the outbreak of VIM-GES-CRPA, a rare strain of extensively drug-resistant P. aeruginosa. …
-
Human Trafficking Awareness and Prevention Month
Instituted in 2010, the United States Department of State dedicates the month of January to raising awareness and…
Trending
-
FDA Approved Semaglutide Injection to Reduce Risk of Serious Heart Problems in Overweight Adults
-
The Role of Pharmacogenomics in Precision Mental Healthcare
-
Why Continuing Education is Essential for NP Career Advancement
-
Beyond Prescriptions: 6 Tips for a Holistic FNP Approach to Psychopharmacology
-
How to Set Boundaries to Avoid NP Burnout
-
Using Technology to Combat Drug-Drug Interactions
-
Ten Key Tips for Balancing School, Work, and Life as an NP Student
-
Top 5 Lab Test Result Interpretation Mistakes (and How to Avoid Them)
-
Understanding Nurse Practitioner Board Exam Options and Benefits
-
Top Pitfalls in Interpreting Common Diagnostic Images and How to Avoid Them
-
OTC COVID-19 Diagnostic Tests May Have an Extended Shelf Life
-
AANP Offers Resources to Help NPs Detect and Treat Ulcerative Colitis
Join our email list
Get new course alerts, newsletters and more delivered directly to your inbox
By providing my personal information, including phone number, I consent to (1) receive email messages with information and offers, autodialed calls, texts, and prerecorded messages from FHEA, including current and possible future services, customer service and billing; and (2) FHEA’s Privacy Policy and Terms and Conditions. I understand that my consent is not required to purchase, and that cancellation of purchase does not automatically revoke this consent.